Aggressive cutaneous NK and NK-like T-cell lymphomas: Clinicopathologic, immunohistochemical, and molecular analyses of 12 cases

American Journal of Surgical Pathology

Volumn 23, Issue 5, 1999, Pages 571-581

  Natkunam, Yasodha ^a   Smoller, Bruce R ^a   Zehnder, James L ^a   Dorfman, Ronald F ^a   Warnke, Roger A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiocentric lymphoma; CD56; Natural killer cell; NK like T cell

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN P; LEUKOSIALIN; MESSENGER RNA; PROTEIN P53;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL FEATURE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EPSTEIN BARR VIRUS; FEMALE; GENE MUTATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NATURAL KILLER CELL; PROTEIN EXPRESSION; SKIN LYMPHOMA; T CELL LYMPHOMA; T LYMPHOCYTE RECEPTOR GENE;

ADOLESCENT; ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; P-GLYCOPROTEIN; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032939150     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199905000-00012     Document Type: Article

References (38)

1. Agarwal ML, Taylor WR, Chernov MV, Chernov OB, Stark GR. The p53 network. J Biol Chem 1998;273:1-4.
2. Ansai SI, Kunihiko M, Yamakawa M et al. CD56-positive (nasal-type T/NK cell) lymphoma arising on the skin. Report of 2 cases and review of the literature. J Cutan Pathol 1997;24:468-476.
3. Arber DA, Weiss LM, Albujar PF, Chen YY, Jaffe ES. Nasal lymphomas in Peru, high incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 1993;17:392-399.
4. Arceci RJ. Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood 1993;81:2215-2222
5. Beck WT, Grogan TM, Willman CL et al. Methods to detect P-glycoprotein associated multidrug resistance in patients' tumors: consensus recommendation. Cancer Research 1996;56:3010-3020.
6. Bindl JM, Warnke RA. Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in Coplin jars. Am J Clin Pathol 1986;85:490-493.
7. Bottaro M, Berti E, Biondi A, Migone N, Crosti L. Heteroduplex analysis for T-cell receptor g gene rearrangement for diagnosis and monitoring of cutaneous T-cell lymphomas. Blood 1994;83:3271-3278.
8. Chan JKC, Ng CS, Ngan KC, Hui PK, Lo STH, Lau WH. Angiocentric T-cell lymphoma of the skin. An aggressive lymphoma distinct from mycosis fungoides. Am J Surg Pathol 1988;12:861-876.
9. Chan JKC, Tsang WYW, Ng CS, Pau MY. Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections. Hum Pathol 1995;26:1139-1143.
10. Chan JK, Tsang WY, Ng CS. Clarification of CD3 immunoreactivity in nasal T/natural killer cell lymphomas: the neoplastic cella are often CD3 epsilon+. Blood 1996;85:2993-2996.
11. Chan JKC, Sin VC, Wong KF, Ng CS, Tsang WYW, Chan CH, Cheung MMC, Lau WH. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89:4501-4513.
12. Chin KV, Ueda K, Pastan I, Gottesman MM. Modulation of the activity of the human mdr-1 gene by ras and p53. Science 1992; 255:459-462.
13. Drenou B, Lamy T, Amiot L, Fardel O, Caulet-Maugendre S, Sasportes M, Diebold J, Le Prise P, Faucet R. CD3-CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. Blood 1997;8:2966-2974.
14. Felgar RE, Macon WR, Kinney MC, Roberts S, Pasha T, Salhany KE. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Am J Pathol 1997;150:1893-1900
15. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci 1987;84:265-269.
16. Ho FCS, Choy D, Loke SL, Kung ITM, Fu KH, Liang R, Todd D, Khoo RKK. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: A clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol 1990;21:1041-1050.
17. Jaffe ES, Chan JKC, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/NK lymphomas: Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996; 20:103-111.
18. Jaffe ES. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood 1996;87:1207-1210.
19. Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusual sites of involvement. Blood 1992;79:2432-2437.
20. Kobashi Y, Nakamura S, Sasajima Y, Koshikawa T, Yatabe Y, Kitoh K, Mori S, Ueda R, Yamabe H, Suchi T. Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occuring in sites other than the upper and lower respiratory tract. Histopathology 1996;28:111-120.
21. Lanier LL, Chang C, Spitz H, Philips JH. Expression of cytoplasmic CD3∈ proteins in activated human adult natural killer (NK) cells and CD3g,d,e complexes in fetal NK cells. J Immunol 1992; 149:1876-1880).
22. LeBoit PE, McCalmont TH. Cutaneous lymphomas and leukemias. In Lever's Histopathology of the skin. Philadelphia: Lippincott-Raven Publishers, 1997;805-846.
23. Macon WR, Williams ME, Greer JP, et al. Natural killer-like T cell lymphomas: Aggressive lymphomas of T-large granular lymphocytes. Blood 1996;87:1474-1483.
24. Marks DI, Vonderheid EC, Kurz BW, et al. Analysis of P53 and MDM2 expression in 18 patients with Sezary syndrome. Brit J Haematol 1996;92:890-899.
25. Mason DY, Krissansen GW, Davey FR, Crumpton MJ, Gatter KC. Antisera against epitopes resistant to denaturation on T3 (CD3) antigen can detect reactive and neoplastic T cells in paraffin embedded tissue biopsy sections. J Clin Pathol 1988;41:121-127.
26. Nakamura S, Suchi T, Koshikawa T et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occuring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1995;19:284-296.
27. Oren M. Lonely no more: P53 finds its kin in a tumor suppressor haven. Cell 1997;90:829-832.
28. Pezzella E, Morrison H, Jones M, Gatler K, Lane D, Harris AL, Mason DY. Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma. Histopathology 1993;22:39-44.
29. Predhomme C, Fenaux P. The clinical significance of mutations of the p53 tumour suppressor gene in haematologic malignancies. Br J Haematol 1997;98:502-511.
30. Quintanilla-Martinez L, Guerrero I, Franklin JL, Naresh KN, Krenacs L, Rama-Rao C, Bhatia K, Magrath IT, Raffeld M. Nasan NK/T-cell lymphoma from Peru. High prevalence of p53 overexpression. Mod Pathol 1998;11:139A.
31. Spits H, Lanier LL, Phillips JH. Development of human T and natural killer cells. Blood 1995;85:2654-2670.
32. Suzuki R, Yamamoto K, Seto M, et al. CD7+ and CD56+ myeloid/ natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood 1997;90:2417-2428.
33. Suzumiya J, Takeshita M, Kimura N, et al. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood 1994;83:2255-2260.
34. Takeshita M, Akamatsu M, Ohshima K, et al. Angiocentric immunoproliferative lesions of the skin show lobular panniculitis and are mainly disorders of large granular lymphocytes. Hum Pathol 1995; 26:1321-1328.
35. Tsang WYW, Chan JKC, Yip TTC, Ng CS, Wong KF, Poon YP, Ma VWS. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphoma. Hum Pathol 1994;25:758-765.
36. Van de Rijn M, Cleary ML, Variakojis D, Warnke RA, Chang, PP, Kamel OW. Epstein-Barr virus clonality in lymphomas in patients with rheumatoid arthritis. Arthritis and Rheum 1996;39:638-642.
37. Van de Rijn M, Bhargava V, Molina-Kirsch H, Carlos-Bregni R, Warnke RA, Cleary ML, Kamel OW. Extranodal head and neck lymphomas in Guatemala: High frequency of Epstein-Barr virus-associated sinonasal lymphomas. Hum Pathol 1997;28:834-839.
38. Wong KF, Chan JKC, Ng CS, Lee KC, Tsang WYW, Cheung MMC. CD56 (NKH-1)-positive hematolymphoid malignancies. Hum Pathol 1992;23:798-804.